Does anthracycline-based chemotherapy in pregnant women with cancer offer safe cardiac and neurodevelopmental outcomes for the developing fetus?
2017 · BMC Cancer · 39 citations
https://doi.org/10.1186/s12885-017-3772-9
M
Marialuisa Framarino‐dei‐Malatesta
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
69
Papers
1.1K
Citations
20
h-index
29
i10-index
Marialuisa Framarino‐dei‐Malatesta is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Pregnancy and Medication Impact & Appendicitis Diagnosis and Management. The author has an h-index of 20, co-authored 59 publications.
ORCID: 0000-0001-7824-7511Papers by this author
worksCytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastases from Endometrial Cancer
2017 · Annals of Surgical Oncology · 17 citations
https://doi.org/10.1245/s10434-017-6307-3
Epirubicin: a new entry in the list of fetal cardiotoxic drugs? Intrauterine death of one fetus in a twin pregnancy. Case report and review of literature
2015 · BMC Cancer · 12 citations
https://doi.org/10.1186/s12885-015-1976-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat